ARB-based hypertension treatment
Release of Rosata tablets
KyungDong Pharm Co., Ltd. will release Rosata tablets, an ARB-based hypertension treatment, on November 1. Rosata tablets are an ARB-based hypertension treatment that contains 50 mg of Losartan potassium. It was released at a price of 630 won with the expiration of the original product's patent in November 2008. Rosata tablets' original product, Korea MSD's Coja tablets, is a large-scale product that has established itself as a leader in the hypertension treatment market, with prescription sales amounting to approximately 80 billion won in 2007 alone. As ARB is currently leading the hypertension treatment market, the marketability of this product is expected to increase in the future.
Rosata Tablet is the first oral ARB hypertension treatment that overcomes the disadvantages of ACEI, which has a high incidence of dry cough. It shows equal or greater effectiveness compared to other drugs in the same ARB series as well as other hypertension treatments, and has the characteristic of maintaining a blood pressure control effect even after long-term use. In addition, it has an excellent kidney protection effect in patients with type 2 diabetes and an excellent cardioprotection effect in patients with left ventricular hypertrophy, so it can be very effective in treating high blood pressure in diabetic patients and preventing cardiovascular disease in patients with high blood pressure with symptoms of left ventricular hypertrophy.
In drug treatment for high blood pressure, about 40% are combination prescriptions of two drugs, and 45% of them are combination prescriptions of ARB treatments and calcium antagonists. Therefore, the launch of Rosata tablets by KyungDong Pharm Co., Ltd. is a combination prescription of Felodipine long-acting tablets (Felodipine 5mg, 2.5mg), KyungDong Pharm Co., Ltd.'s flagship product that has been used for a long time in the calcium antagonist market, and Rosata tablets, raising expectations for future sales growth.
《Rosata Tablet Product Information》
○ Ingredient content: Losartan potassium 50mg (45.8mg as Losartan)
○ Effectiveness: 1. Treatment of high blood pressure.
2. As a treatment for high blood pressure, renal disease in type 2 diabetic patients with high blood pressure.
○ Dosage: 1 tablet once a day, dosage can be increased up to 2 tablets once a day.
○ Insurance price: 630 won/tablet (launched in November 2008)
○ Insurance code: A17604081
※ Please refer to the product manual for more details.